DocSym
β
Searchsearch
Search
(Q56.1) Male pseudohermaphroditism, not elsewhere classified
More details coming soon
7 198 in individuals diagnosis male pseudohermaphroditism, not elsewhere classified confirmed
Diagnosis male pseudohermaphroditism, not elsewhere classified is diagnosed Women are 18.12% more likely than Men
2 947
Men receive the diagnosis male pseudohermaphroditism, not elsewhere classified
0 (less than 0.1%)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
4 251
Women receive the diagnosis male pseudohermaphroditism, not elsewhere classified
0 (less than 0.1%)Died from this diagnosis.
Risk Group for the Disease male pseudohermaphroditism, not elsewhere classified - Men aged 0 and Women aged 15-19
In Men diagnosis is most often set at age 0-5, 10-24, 35-39, 60-64
Less common in men the disease occurs at Age 5-9, 25-34, 40-59, 65-95+Less common in women the disease occurs at Age 25-29, 35-44, 50-95+
In Women diagnosis is most often set at age 0-24, 30-34, 45-49
Disease Features male pseudohermaphroditism, not elsewhere classified
Absence or low individual and public risk
Male pseudohermaphroditism, not elsewhere classified - what does this mean
Male pseudohermaphroditism, not elsewhere classified, is a rare disorder caused by a genetic mutation that results in the development of both female and male sex characteristics, such as ambiguous genitalia, during fetal development. this disorder can be caused by a variety of genetic mutations, including mutations of the sry gene or mutations of the androgen receptor gene.
What happens during the disease - male pseudohermaphroditism, not elsewhere classified
Male pseudohermaphroditism, not elsewhere classified is a condition in which the genetic and hormonal make-up of a male does not match the external genitalia. it is caused by a disruption in the normal development of the reproductive organs due to a mutation in the sry gene, which is responsible for male sexual development, or due to environmental factors such as exposure to certain hormones during fetal development. this can lead to ambiguous genitalia and a variety of other symptoms, including infertility, a lack of secondary sexual characteristics, and a range of hormonal imbalances.
Clinical Pattern
More details coming soon
How does a doctor diagnose
More details coming soon
Treatment and Medical Assistance
More details coming soon
8 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Male pseudohermaphroditism, not elsewhere classified - Prevention
Male pseudohermaphroditism, not elsewhere classified, can be prevented by controlling exposure to environmental toxins, such as pesticides, and by avoiding the use of certain medications during pregnancy. additionally, proper prenatal care and monitoring of fetal development should be undertaken to reduce the risk of male pseudohermaphroditism.